FACT facilitates chromatin transcription by RNA polymerases I and III by Birch, Joanna L et al.
EMBO
open
FACT facilitates chromatin transcription by RNA
polymerases I and III
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
distribution,andreproductioninanymedium,providedtheoriginalauthorandsourcearecredited.Thislicensedoesnot
permit commercialexploitationwithout speciﬁc permission.
Joanna L Birch
1,6, Bertrand C-M Tan
2,6,
Kostya I Panov
1,7, Tatiana B Panova
1,8,
Jens S Andersen
3, Tom A Owen-Hughes
1,
Jackie Russell
1, Sheng-Chung Lee
4,5
and Joost CBM Zomerdijk
1,*
1Wellcome Trust Centre for Gene Regulation and Expression, College
of Life Sciences, University of Dundee, Dundee, UK,
2Department of
Life Sciences, Chang Gung University, Kwei-Shan Tao-Yuan, Taiwan,
3Department of Biochemistry and Molecular Biology, University of
Southern Denmark, Odense, Denmark,
4Institute of Molecular Medicine,
College of Medicine, National Taiwan University, Taipei, Taiwan and
5Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
Efﬁcient transcription elongation from a chromatin tem-
plate requires RNA polymerases (Pols) to negotiate nucleo-
somes. Our biochemical analyses demonstrate that RNA Pol
I can transcribe through nucleosome templates and that
this requires structural rearrangement of the nucleosomal
core particle. The subunits of the histone chaperone FACT
(facilitates chromatin transcription), SSRP1 and Spt16, co-
purify and co-immunoprecipitate with mammalian Pol I
complexes. In cells, SSRP1 is detectable at the rRNA gene
repeats. Crucially, siRNA-mediated repression of FACT sub-
unit expression in cells results in a signiﬁcant reduction in
47S pre-rRNA levels, whereas synthesis of the ﬁrst 40nt of
the rRNA is not affected, implying that FACT is important
for Pol I transcription elongation through chromatin. FACT
also associates with RNA Pol III complexes, is present at the
chromatin of genes transcribed by Pol III and facilitates
their transcription in cells. Our ﬁndings indicate that,
beyond the established role in Pol II transcription, FACT
has physiological functions in chromatin transcription by
all three nuclear RNA Pols. Our data also imply that local
chromatin dynamics inﬂuence transcription of the active
rRNA genes by Pol I and of Pol III-transcribed genes.
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Introduction
Eukaryotic gene expression can be regulated at various key
steps in the transcription cycle, including the recruitment of
the RNA polymerase (Pol) to the gene promoter, transcription
initiation, promoter escape, elongation and termination, and
the rate of RNA synthesis is dependent upon the efﬁciency by
which RNA Pols negotiate nucleosomes in chromatin
(Saunders et al, 2006; Li et al, 2007). At physiological salt
concentrations, nucleosomes impose a strong block to elon-
gation of RNA Pol II transcription in vitro (Kireeva et al,
2002). Pol II chromatin transcription is facilitated by histone
chaperones, such as FACT (facilitates chromatin transcrip-
tion; Orphanides et al, 1998), which aid Pol II passage by
destabilizing the nucleosome through the transient release
of a histone H2A–H2B dimer (Orphanides et al, 1999;
Belotserkovskaya et al, 2003), consistent with the observed
rapid exchange of these dimers in cells (Kimura and Cook,
2001). RNA Pol III possesses an intrinsic ability to transcribe
through a mono-nucleosome by translocation of the nucleo-
some to a position upstream of its original site during
polymerase passage without disruption of the majority of
histone octamer–DNA contacts (Studitsky et al, 1997). Our
initial aim was to identify RNA Pol I-associated proteins and
activities important for rRNA gene transcription through
chromatin in vitro and in cells.
Transcription of the major ribosomal RNAs by Pol I is a key
determinant of ribosome biogenesis, driving cell growth and
proliferation in eukaryotes. Of the hundreds of copies of
rRNA genes present in each cell, only a proportion are
transcribed in actively growing cells of yeast or humans
(B50% of the rDNA repeats are transcribed in interphase
cells; Conconi et al, 1989) and the cellular control of Pol I
transcription involves adjustments both to the number of
rRNA genes actively engaged in transcription and the rate of
transcription from each active gene (reviewed in Grummt,
2003; Moss, 2004; Russell and Zomerdijk, 2005). Chromatin
context inﬂuences the transcriptional activity of the rDNA
genes (reviewed in Birch and Zomerdijk, 2008) and, conver-
sely, passage of the transcription machinery affects chromatin
structure (Dammann et al, 1995).
Inactive or silent rDNA genes have a chromatin structure
distinct from that of active rDNA genes. Inactive rDNA
repeats are in a chromatin state relatively refractory to
psoralen crosslinking and organized in regular nucleosomal
arrays similar to those observed for bulk chromatin (Conconi
et al, 1989; Dammann et al, 1993). They are maintained in a
silent state through association of the nucleolar remodelling
complex (NoRC) with the rDNA promoter in mammalian
cells (Strohner et al, 2001; Santoro et al, 2002). The actively
transcribed rDNA repeats associated with nascent rRNA re-
side in a psoralen-accessible (‘open’) chromatin state lacking
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854regular nucleosomal arrays (Conconi et al, 1989; Dammann
et al, 1993). Active rDNA repeats in Saccharomyces cerevisiae
have relatively few (Jones et al, 2007), if any (Merz et al,
2008), histones associated with the transcribed regions, yet
there is evidence for a dynamic nucleosomal arrangement in
both budding yeast and the slime mould Physarum (French
et al, 2003; Thiriet and Hayes, 2005) and for the association of
chromatin remodelling activities at actively transcribed rRNA
genes in yeast (Schneider et al, 2006; Jones et al, 2007). In
mammalian rDNA, nucleosomes are present at the rDNA
promoter regions of both active and inactive repeats though,
signiﬁcantly, the active and silent mammalian rDNA promo-
ters are distinguishable by differential nucleosome position-
ing (Langst et al, 1998; Li et al, 2006), histone modiﬁcations
and DNA methylation (Santoro et al, 2002; Nemeth et al,
2008). The nucleosomal arrangement at the transcribed
regions of the mammalian rRNA genes is currently unknown.
One contributory inﬂuence on the chromatin status of mam-
malian rDNA genes is Pol I transcription factor UBF, a protein
with multiple HMG boxes, with the abilities to stimulate
promoter escape (Panov et al, 2006a) and modulate Pol I
transcription elongation rates (Stefanovsky et al, 2006), as
well as, to decondense rDNA chromatin (Chen et al, 2004;
Mais et al, 2005; Wright et al, 2006).
Passage of the polymerase through a chromatin template is
a potential control point for Pol I transcription, whether at
active rRNA repeats or during de novo activation of pre-
viously silent repeats. Here, we provide evidence that the
histone chaperone FACT, a heterodimer of Spt16 and SSRP1
(Orphanides et al, 1999), associates with Pol I and with rRNA
gene repeats in cells. We demonstrate that a Pol I complex
with associated FACT has the capacity to transcribe through
mono- and poly-nucleosomal templates in vitro. Crucially,
downregulation of FACTsubunit expression in cells leads to a
reduction in pre-rRNA synthesis due to a decrease in Pol I
transcription elongation. Collectively, our data suggest a role
for Pol I-associated FACT, as a histone chaperone, in passage
of Pol I through chromatin templates in cells. Furthermore,
our ﬁndings are highly suggestive of the presence of nucleo-
somes on the transcribed regions of the active mammalian
rRNA genes.
We extended these studies to include an analysis of RNA
Pol III-transcribed genes. Chromatin immunoprecipitation
(ChIP) and siRNA experiments suggest that FACTalso associ-
ates with Pol III genes and facilitates Pol III transcription in
chromatin.
Our data complement previous ﬁndings that implicated
FACT in Pol II transcription (Orphanides et al, 1998;
Belotserkovskaya et al, 2003; Saunders et al, 2003), thereby
suggesting a role for histone chaperone FACT in chromatin
transcription by all three nuclear RNA Pols.
Results
Pol I is able to transcribe through nucleosomes in vitro
A mono-nucleosomal template was generated using recombi-
nant Xenopus histones and a 178-bp DNA fragment contain-
ing the MMTV nucleosome positioning sequence (NPS) A
and an additional 31bp of DNA to allow an entry point for the
polymerase (Figure 1A, diagram and lane 1). Pol Ia, puriﬁed
from HeLa cell nuclear extracts in a multistep process that
separates Pol Ia from the less abundant Pol Ib complex, and
then further puriﬁed over a Mono-S column (Miller et al,
2001), was incubated with the mono-nucleosomal template in
a transcription reaction mix. Pol Ia was able to transcribe
through the nucleosome to yield a full-length transcript of
178nt (Figure 1B, lane 1). This 178nt transcript resulted from
Pol I transcription of the mono-nucleosomal template (N;
Figure 1A, lane 1), rather than from transcription of residual
nucleosome-free DNA (RF; Figure 1A, lane 1; o5% of total
DNA) in the mono-nucleosomal preparation. Evidence to
support this conclusion includes the ﬁnding that restriction
enzyme AvaII digestion of all the residual nucleosome-free
DNA into fragments of 122 and 56bp (Figure 1A, lane 2; the
nucleosome protects the mono-nucleosomal template, N,
from digestion) did not signiﬁcantly affect production of the
178nt transcripts (Figure 1C, compare lanes 1 and 2) or,
detectably, yield transcripts of 122 and 56nt. (Note that, at
the relatively low concentration of AvaII used, the nucleo-
some-free DNA, F, is only partially digested, hence there is
substantial production of the full-length 178nt transcripts in
addition to the synthesis of 122 and 56nt transcripts from the
AvaII-digested fragments; Figure 1C, lane 3.)
Pol I transcription from the nucleosomal template (N) was
consistently 10-fold less than that from the same amount of
nucleosome-free DNA template (F) (Figure 1B, compare lanes
1 and 2), suggesting that the nucleosome presents a signiﬁ-
cant but not insurmountable barrier to efﬁcient transcription
elongation by Pol I.
We next asked whether Pol I could transcribe through a
template with an array of nucleosomes. A poly-nucleosomal
template was generated, comprising a DNA template that
includes twelve 5S rDNA nucleosome-positioning sequences
and histone octamers (Figure 1D). The nucleosomal compo-
sition of this template was analysed by MNase digestion,
which produced a DNA ladder upon digestion of poly-
nucleosomal DNA (Figure 1D, lane 3). Pol Ia was able to
transcribe the poly-nucleosomal template (poly-N) proces-
sively to yield a full-length transcript of 2496nt (Figure 1E,
lane 1). The efﬁciency of transcription was B10-fold less on
the poly-nucleosomal template (poly-N) compared with that
on the same amount of the equivalent nucleosome-free
template (F) (Figure 1F, compare lanes 1 and 2) and similar,
therefore, to the efﬁciency of transcription on the mono-
nucleosomal template. Substitution of AMP-PNP for ATP
reduced overall transcription levels as AMP-PNP is less read-
ily utilized by Pol I, but the ratio of transcription from the
poly-nucleosomal compared with the nucleosome-free tem-
plate remained approximately 1:10, implying that no ATP-
dependent chromatin remodelling activity is required for
chromatin transcription by Pol I in vitro (Figure 1F, compare
lanes 3 and 4). Collectively, the data suggest that the Pol Ia
complex has the ability to negotiate nucleosomes in tran-
scription.
Pol I transcription is inhibited by the presence
of crosslinked histones
To test whether Pol I might negotiate the nucleosomal barrier
through rearrangement of histones in the octamer DNA, we
used a homo-bifunctional crosslinking reagent bis(sulpho-
succinimidyl) suberate (BS
3) to crosslink histones within a
pre-formed nucleosomal core particle. Nucleosomal DNA
templates crosslinked with BS
3 (Figure 2A, lane 2) were
incubated with Pol Ia in an end-to-end transcription assay.
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3, treated with
BS
3 inactivated by glycine treatment or untreated were used
as controls. There was a marked inhibition of nucleosomal
transcription by Pol I on the crosslinked nucleosomal tem-
plates (Figure 2B, lanes 1 and 2 and graph), in comparison
with the controls (Figure 2B, lanes 3–8 and graph). These
results suggest that structural rearrangement of the nucleo-
somal core particle is necessary to enable Pol I passage.
FACT associates with puriﬁed Pol Ia and with Pol I, II and
III complexes from HeLa cell nuclear extracts
The ability of Pol Ia to transcribe through a nucleosome, by
way of structural rearrangement of the nucleosomal core
particle, could be an intrinsic property of core Pol I or the
activity of an associated protein or proteins. Pol Ia was
puriﬁed as described previously (Miller et al, 2001) and the
peak Pol I fraction from the Mono-S column was separated
into its component proteins on a denaturing gel and SYPRO
Ruby-stained (Figure 3A). Bands migrating at B130 and
B80kDa, with intensities similar to those for the largest
and second largest subunits of Pol I (hRPA190 and
hRPA135), were identiﬁed by mass spectrometry as subunits
Spt16 (SUPT16H, an orthologue of S. cerevisiae SPT16/
CDC68; Malone et al, 1991; Rowley et al, 1991) and SSRP1
(structure speciﬁc recognition protein 1; Bruhn et al, 1992),
respectively, of the histone chaperone FACT (Orphanides
et al, 1999). The gradient salt elution proﬁles from the
Mono-S column were similar for FACT subunit SSRP1, Pol I
subunit hRPA19 (AC19) and Pol I transcriptional activity
A
B
F
 N   F 
178 bp
12
34
ATP
AMP-PNP
Rel. transcr.
Rel. transcr.
Pol Iα
AvaII
122 56
AvaII
191
96
68
2496 nt
Poly-N
F
C
E
D
(nt)
Poly-N
F
Poly-N
F
31 147
2 1
178 nt
178 nt
122 nt
56 nt
4 2 13
+ – + –
2 1
1.0 10.3
1.0 11.3
2496 nt
MNase + –
 Poly-N 
Slot
2 13
11.1 1.0 Rel. transcr.
2496 nt
178
122
56
N 
2 1
 N   F 
191
96
68
RF 
 RF 
Cy5
AvaII + –
*
*
*
*
Figure 1 Pol Ia can transcribe through nucleosomal DNA in vitro.
(A) Diagram of the reconstituted mono-nucleosomal template.
A3 0-end Cy5-labelled 178-bp DNA fragment containing the
MMTV nucleosome positioning sequence A and an additional
31bp was reconstituted with recombinant histone octamers and
analysed by 5% native polyacrylamide gel electrophoresis and Cy5
imaging (lane 1; N, mono-nucleosomal DNA; RF, residual nucleo-
some-free DNA). The presence of the nucleosome protects the AvaII
site from digestion; AvaII digestion yields 122- and 56-bp DNA
fragments (at the bottom of the gel) from the residual nucleosome-
free DNA (lane 2), as revealed following SYPRO Green staining. (B)
Mono-nucleosomal (N, lane 1) or nucleosome-free (F, lane 2) DNA
templates were incubated with Pol Ia in a transcription reaction
mix. Radiolabelled full-length transcripts (178nt) were analysed on
a 7.5M urea 11% polyacrylamide gel and quantiﬁed with the aid of
a phosphorimager. Transcript levels are expressed relative to the
levels of transcripts detected in the nucleosomal transcription
reactions (set at 1.0; rel. transcr.). (C) The 178nt transcripts
generated in Pol Ia transcription reactions with a mono-nucleoso-
mal template are not due to transcription of residual nucleosome-
free DNA in that reaction. Pol Ia transcription reactions (as in (B))
through a mono-nucleosomal (N, lanes 1 and 2) or nucleosome-free
(F, lanes 3 and 4) DNA template were performed in the absence
(lanes 2 and 4) or presence (lanes 1 and 3) of AvaII. Transcripts
were analysed as in (B); full-length transcripts of 178nt and smaller
transcripts of 122 and 56nt, produced from AvaII-digested DNA
templates, are indicated on the right of the gel image. RNA size
markers are shown on the left of the gel image. Bands marked with
an asterisk (*) are nonspeciﬁc background signals, largely indepen-
dent of the level of Pol I transcription. (D) Diagram of the recon-
stituted poly-nucleosomal template. A linear DNA fragment of
2496bp containing twelve 5S nucleosome-positioning sequences
was reconstituted into chromatin (Poly-N) and a sample was
analysed on a native 2% polyacrylamide–1% agarose composite
gel, stained with SYPRO Green and scanned for ﬂuorescence (left
panel; RF indicates the residual nucleosome-free DNA following the
reconstitution reaction). The Poly-N DNA, untreated (lane 2, right
panel) or limit-digested with MNase (lane 3, right panel), was
analysed on a 1.2% agarose gel and ethidium bromide-stained. A
DNA size marker (100bp ladder) was run in lane 1 (right panel). (E)
Pol Ia transcription reactions with poly-nucleosomal (Poly-N, lane
1) or an equivalent amount of nucleosome-free (F, lane 2) DNA
template (0.3mg). Radiolabelled transcripts were analysed on an 8%
denaturing polyacrylamide gel and detected by phosphorimaging.
The full-length transcript signal is indicated. (F) Pol Ia transcription
reactions with poly-nucleosomal (Poly-N, lanes 1 and 3) or non-
nucleosomal (F, lanes 2 and 4) DNA templates (0.3mg), included
either NTPs (lanes 1 and 2) or an NTP mixture with a non-
hydrolysable analogue of ATP, AMP-PNP, substituted for ATP
(lanes 3 and 4). Radiolabelled transcripts (2496nt) were analysed
on a 1.2% formaldehyde-agarose gel and detected by phosphorima-
ging. Transcript levels were quantiﬁed and expressed as in (B).
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Ia. That these FACT subunits had not been noted previously
in highly puriﬁed mammalian Pol I complexes (for example,
Matsui et al, 1976; Rose et al, 1988; Song et al, 1994; Hanada
et al, 1996; Seither et al, 1997; Hannan et al, 1998; Yamamoto
et al, 2004) might reﬂect differences in the way the complexes
were puriﬁed.
Therefore, to determine whether indeed FACT associates
with Pol I complexes, we analysed FACT co-immunoprecipi-
tation with Pol I from Pol Ia fractions and, also, from nuclear
extracts. Pol Ia was incubated with antibodies speciﬁc to
SSRP1, or with control nonspeciﬁc IgGs, and immunopreci-
pitated complexes on the antibody beads were assayed for Pol
I transcription activity. The SSRP1-speciﬁc antibodies immu-
noprecipitated Pol I transcription activity (Figure 3C), sug-
gesting that the SSRP1 subunit of FACT is in a complex with
Pol I. This transcriptional activity was lower than that of the
input (see IgG supernatant), probably because the polymer-
ase was tethered to beads. There was little Pol I activity
detectable in the supernatant following immunoprecipitation
with SSRP1- (Figure 3C) or Spt16-speciﬁc antibodies (data
not shown), suggesting that the immunoprecipitation was
efﬁcient and association with Pol Ia is stoichiometric; the
SYPRO Ruby staining pattern of FACT and Pol I subunits
(Figure 3A) is consistent with such stoichiometry.
To determine whether Spt16 can associate with Pol I, Pol Ia
was incubated with Spt16-speciﬁc antibodies and immuno-
precipitates were immunoblotted using PAF53-speciﬁc anti-
bodies. The Spt16-speciﬁc antibodies co-immunoprecipitated
the Pol I-speciﬁc subunit PAF53 (Hanada et al, 1996; Seither
et al, 1997; Figure 3D, lane 2), suggesting that the Spt16
subunit of FACT associates with Pol I.
To examine the association of FACT with Pol I in the
context of a more complex protein mixture, Pol I was
immunoprecipitated from nuclear extracts of HeLa cells ex-
pressing Flag-tagged Pol I-speciﬁc subunit CAST/hPAF49
(Panov et al, 2006b) and Flag-antibody immunoprecipitates
were analysed by immunoblotting using Spt16- and PAF53-
speciﬁc antibodies. Spt16 was detectable in the Pol I immuno-
precipitates (Figure 3E, lane 3). Therefore, FACT associates
both with puriﬁed Pol Ia complexes and with Pol I complexes
from HeLa cell nuclear extracts.
Previously, we have isolated and biochemically deﬁned the
much less abundant initiation-competent Pol Ib complexes,
characterized by the presence of hRRN3, which bridges the
interaction between promoter-bound SL1 and Pol I (Miller
et al, 2001). To test whether or not FACT could be found
associated with these Pol I complexes, we used hRRN3-
speciﬁc antibodies to immunoprecipitate Pol Ib from an
intermediate Pol I chromatography fraction that contains
both Pol Ia and Pol Ib (0.2M DEAE fraction; Miller et al,
2001) and analysed the immunoprecipitates using Spt16-,
RPA190- and PAF53-speciﬁc antibodies in immunoblotting.
The low-abundance Pol Ib complexes were immunoprecipi-
tated speciﬁcally (Figure 3F, compare lane 4 with lane 1), but
no hSpt16 was detectable in the Pol Ib immunoprecipitates
(Figure 3F, lane 4), despite the presence of hSpt16 in the
fraction that contains both forms of Pol I (Figure 3F, lane 2).
These data suggest that FACT is not associated stoichiome-
trically with Pol Ib, implying that FACT could become asso-
ciated with Pol I following initiation of transcription.
The association of FACT with the human Pol Ia complex
(Figure 3A–D) and the interaction of FACTwith Pol II detected
in Drosophila cell extracts (Saunders et al, 2003) led to the
possibility that FACT might also interact with Pol III. We
tested whether immunoprecipitation of FACT, using SSRP1-
speciﬁc antibodies would co-precipitate the three nuclear
RNA Pols from HeLa nuclear extracts. Immunoprecipitates
were analysed by immunoblotting using antibodies speciﬁc
to Pol I subunit CAST, the Pol II largest subunit (C-terminal
domain) and Pol III subunit RPC5. The subunits of all three
polymerases were detectable in the SSRP1 immunoprecipitates,
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Figure 2 Pol I transcription of a mono-nucleosomal template is
inhibited by crosslinking of the histones within the nucleosome. (A)
Crosslinking of the histones in the octamer of the mono-nucleoso-
mal template with the homo-bifunctional crosslinker bis(sulpho-
succinimidyl) suberate (BS
3). Histones from the BS
3-treated (lane 2)
and untreated (lane 3) mono-nucleosomal templates were analysed
on a 4–12% gradient denaturing protein gel, SYPRO Ruby-stained.
The positions of free histones and crosslinked histone octamers are
marked. Lane 1 contains a protein size marker. (B) Duplicate
transcription reactions contained the mono-nucleosomal 178bp
DNA template (0.3mg) pretreated with BS
3 (þ, lanes 1 and 2),
inactivated BS
3 (þ
i lanes 3 and 4) or crosslinking buffer alone ( ,
lanes 5 and 6), or untreated (control C, lanes 7 and 8). Radiolabelled
transcripts were analysed by 7.5M urea 11% polyacrylamide gel
electrophoresis and phosphorimaging. The position of the full-
length transcript (178nt) from a representative experiment is in-
dicated (as determined using a radiolabelled RNA size marker). The
graph shows the results of duplicate reactions from two indepen-
dent experiments; average transcript (178nt) levels are expressed in
arbitrary units (AU) and the ranges are indicated.
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nuclear extract co-immunoprecipitated with FACT, relative
to the proportions of the co-immunoprecipitating Pol II and III
subunits (Figure 3G, lane 3). Control immunoprecipitations,
which included ethidium bromide or DNase I (Tan et al,
2006), suggested that the association of FACT with the RNA
Pols was independent of DNA (data not shown). The associa-
tion of FACT with all three nuclear RNA Pols leads us to
speculate that FACT might interact with a conserved subunit
shared by the three, as has been observed for yeast chromatin
remodeller RSC (Soutourina et al, 2006).
SSRP1-speciﬁc antibodies selectively inhibit
nucleosomal transcription by Pol Ia
FACT facilitates transcription by Pol II through nucleosomes
(Orphanides et al, 1998, 1999; Belotserkovskaya et al, 2003)
and could perform a similar role in Pol I transcription.
Preincubation of Pol Ia with SSRP1-speciﬁc antibodies
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Figure 3 FACTassociates with puriﬁed Pol Ia and with Pol I, II and III complexes from HeLa cell nuclear extract. (A) Mono-S fraction of Pol Ia,
puriﬁed from HeLa cell nuclear extracts in a multistep process as detailed in the Materials and methods, was separated into its subunits and
associated proteins on a 4–12% gradient denaturing protein gel and SYPRO-Ruby stained (see also Panov et al, 2006b). The bands representing
the SSRP1 (structure-speciﬁc recognition protein, B80kDa) and Spt16 (B130kDa) subunits of FACT, as identiﬁed by mass spectrometric
analysis, and the positions of nine of the core Pol I subunits (following the nomenclature in Panov et al, 2006b) are indicated. (B) Pol Ia
gradient salt-eluted fractions from the Mono-S column were analysed for Pol I transcription activity in a nonspeciﬁc transcription assay (graph,
fractions 15–29; inclusion of 0.1mg/ml a-amanitin does not affect RNA synthesis activity; Miller et al, 2001) and by immunoblotting (fractions
18–26) using antibodies speciﬁc for SSRP1 (upper panel) and for Pol I subunit hRPA19 (lower panel). (C) Antibodies speciﬁc for SSRP1 or
control IgG were used for immunoprecipitation of Pol Ia (peak activity from the Mono-S column) and the immunoprecipitates (IP, beads) and
supernatants (Sup, following IP) were analysed for Pol I transcription activity in a nonspeciﬁc transcription assay. Transcript levels from two
independent experiments were quantiﬁed, expressed as a percentage of maximum, set at 100%, and plotted as the average and range. (D)
Antibodies speciﬁc for Spt16 (lanes 1 and 2) or control IgG (lanes 3 and 4) were used for immunoprecipitation from Pol Ia (as above) and the
immunoprecipitates (IP, lanes 2 and 4) and supernatants (Sup, lanes 1 and 3) were analysed by immunoblotting using antibodies speciﬁc for
Pol I subunit hPAF53. (E) Pol I was immunoprecipitated through the Flag epitope from nuclear extracts of HeLa cells expressing Flag-tagged Pol
I subunit CAST. Flag antibody immunoprecipitates (Flag-IP, lane 3), the supernatants (10%) of the immunoprecipitation (Sup, lane 2) and
control immunoprecipitates (IgG-IP, lane 1) were immunoblotted with antibodies speciﬁc for Spt16 and Pol I subunit PAF53. (F) Pol Ib was
immunoprecipitated through hRRN3 from a chromatography fraction containing both Pol Ia and Ib (0.2M KCl DEAE fraction; Miller et al,
2001). hRRN3-antibody immunoprecipitates (lane 4), the supernatant (10%) left following immunoprecipitation (lane 2), control immuno-
precipitation with IgG (lane 1) and a control fraction (C) of puriﬁed Pol Ia (containing FACT; lane 3) were immunoblotted with antibodies
speciﬁc for Spt16 and human Pol I subunits RPA190 and PAF53. (G) Immunoprecipitation of FACTand associated RNA polymerases from HeLa
cell nuclear extracts. Immunoprecipitation (IP) was performed with the SSRP1 mouse monoclonal (10D1) antibody (lane 3) or with control
mouse IgG (lane 2). Immunocomplexes were boiled in SDS sample buffer and subsequently analysed by SDS–PAGE and immunoblotting using
antibodies speciﬁc for FACTsubunits SSRP1 and hSpt16, Pol I subunit CAST, Pol II largest subunit CTD4H8 and Pol III subunit RPC5. In lane 1,
1.5% of the input (In) nuclear extract was loaded.
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somal template (Figure 4, lane 2 and graph). This inhibition
of transcription is speciﬁc for the nucleosomal template (N)
as SSRP1-antibody preincubation of Pol I did not affect
transcription from the nucleosome-free template (F)
(Figure 4, lane 1 and graph). These data suggest a role for
FACT in facilitating transcription by Pol I (at near-physio-
logical salt concentrations) of nucleosomal templates.
Our preliminary data suggest that in transcription reactions
with mono-nucleosomal templates, Pol Ia facilitates the loss
of Cy3-labelled H2B from the template (see Supplementary
Figure S1). These data are also consistent with the ascribed
histone chaperone activity of FACT, which destabilizes the
histone octamer and facilitates the release of a single histone
H2A–H2B dimer from the nucleosome to promote passage
by transcribing Pol II (Orphanides et al, 1998, 1999;
Belotserkovskaya et al, 2003). We conclude that FACT
might operate similarly to facilitate chromatin transcription
by Pol I.
FACT is associated with transcriptionally active rRNA
genes in the nucleolus
To further characterize the association of FACTwith Pol I, we
examined the subcellular distribution of endogenous FACT in
mammalian cells. Immunostaining analysis revealed that a
fraction of SSRP1 resides in the nucleoli (Figure 5), with a
distribution similar to that of Pol I subunit CAST/hPAF49.
Treatment of cells with a low concentration of actinomycin D,
which primarily inhibits Pol I transcription (Perry and Kelley,
1970), resulted in the disappearance of the FACTsubunit from
the nucleoli (Figure 5), with a similar pattern of redistribution
observed for CAST/hPAF49, which underwent translocation
from the nucleolus to the nucleoplasm. These data suggest
that nucleolar localization of FACT requires ongoing rDNA
transcription and the presence of Pol I in the nucleolus.
Furthermore, the data are consistent with a role for FACT in
modifying nucleosomal structures at the active rRNA genes
in vivo, and support the possibility of a direct link between
FACT and Pol I transcription in cells.
FACT is associated with the chromatin of Pol I- and
III-transcribed genes in cells
To explore whether FACT is associated with the rDNA chro-
matin in cells, the rDNA occupancy of FACTwas examined by
ChIP. Crosslinked chromatin was precipitated with an SSRP1-
speciﬁc monoclonal antibody. Subsequent PCR reactions
used primers for the ampliﬁcation of the rDNA promoter,
three regions within the transcribed sequence of human
rDNA (50-ETS, 18S and 28S) and a sequence within the
non-transcribed intergenic spacer (IGS) (Figure 6A). The
ChIP results suggest that FACT is associated with the promo-
ter and the transcribed regions of the rDNA repeats
(Figure 6B). SSRP1 occupancy of the transcribed regions of
the rDNA repeat was comparable to that of the Pol II-
transcribed g-actin gene. Furthermore, FACT was found at
various Pol III-transcribed genes, including the 5S rRNA, U6
snRNA, tRNA
Tyr and 7SL RNA genes, with type 1 (5S rRNA
gene), 2 (tRNA genes) and 3 (U6 snRNA gene) promoters
(Figure 6B).
Downregulation of FACT expression decreases Pol I and
Pol III transcription in cells
The involvement of FACT in rRNA synthesis by Pol I in cells
was further examined by downregulation of SSRP1 expres-
sion through RNA interference. RNAi-mediated downregula-
tion of SSRP1 (to o20% of control; Figure 7A, lane 4) led to a
reduction in 47S pre-rRNA levels (Figure 7B, lanes 3 and 4
compared with lanes 1 and 2, respectively) of about
two-fold post-transfection of SSRP1-speciﬁc siRNAs into
HeLa cells (Figure 7B, graph). Furthermore, a substantial
decrease in nascent pre-rRNA levels was observed by
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Figure 4 SSRP1-speciﬁc antibodies selectively inhibit nucleosomal
transcription by Pol Ia. Pol Ia was pre-incubated with SSRP1
antibodies (1mg, sc-25382; lanes 1 and 2), with control rabbit
IgGs (lanes 3 and 4) or in buffer alone (lanes 5 and 6) prior to
incubation with mono-nucleosomal templates (N; lanes 2, 4 and 6)
or nucleosome-free templates (F; lanes 1, 3 and 5) in a transcription
reaction mix. Radiolabelled transcripts were analysed by 7.5M urea
11% polyacrylamide gel electrophoresis and phosphorimaging. The
two RNA bands around 178nt are the products of bi-directional
end-to-end transcription; due to the asymmetrical nature of the
nucleosomal template, Pol I favours one DNA-end over the other.
The 178-nt transcripts levels of two independent experiments were
quantiﬁed (in arbitrary units) with the aid of a phosphorimager. The
data of duplicate samples are presented as the average and range.
Note the two scales for the Yaxis; transcription signals (in arbitrary
units) from the nucleosomal template (N, black bars) are approxi-
mately 10 times lower than those from the equivalent nucleosome-
free DNA template (F, white bars).
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Figure 5 Subcellular localization of FACT and Pol I. Indirect im-
munoﬂuorescence analysis was performed on HeLa cells to observe
localization of endogenous SSRP1 (red) and CAST/hPAF49 (green).
Before immunostaining, HeLa cells were cultured in the presence of
50ng/ml actinomycin D for 30min to inhibit Pol I activity (þAct D)
or in its absence ( Act D). Nuclear DNA was stained by DAPI
(blue). Images were captured by laser scanning confocal micro-
scopy and single sections are shown (scale bar is 10mm).
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(Leung et al, 2004) of newly synthesized RNA in the nucleoli
of HeLa cells in which SSRP1 expression was downregulated
by the SSRP1-speciﬁc dsRNA (Figure 7C). Notably, there was
no detectable effect of SSRP1-siRNA on synthesis of the ﬁrst
40nt of the pre-rRNA transcript (Figure 7D). Reductions in
47S pre-rRNA levels similar to those observed with synthetic
siRNA for SSRP1 (Figure 7B) were obtained in a different
RNAi experimental set-up, in which expression plasmids
encoding an SSRP1- or Spt16-speciﬁc dsRNAwere transfected
into HeLa cells (Figure 7E).
Collectively, these results suggest that FACT has a speciﬁc
function in rDNA transcription by Pol I and, crucially, that
FACT appears to function at a stage following pre-initiation
complex formation, initiation of transcription and transcrip-
tion of the ﬁrst 40nt. The observed downregulation of rRNA
synthesis is not, then, an indirect effect of decreased Pol II
transcription leading to reduced availability of Pol I transcrip-
tion initiation components. The ﬁnding that siRNA-mediated
downregulation of FACT subunit expression reduces tran-
scription elongation by Pol I through the rRNA genes is
consistent with a role for FACT as a histone chaperone
in facilitating Pol I transcription elongation through rDNA
chromatin.
We also explored the possibility of a role for FACT in
facilitating chromatin transcription of Pol III-transcribed
genes by analysing the effects of RNAi-mediated downregula-
tion of SSRP1 on the transcription of these genes. The data
indicate that downregulation of SSRP1 also reduced the levels
of tRNA
Tyr and 7SL RNA (Figure 7F), suggesting the involve-
ment of FACT in Pol III transcription in cells.
In summary, we have demonstrated an important role for
RNA Pol I-associated FACT in rRNA gene transcription
through chromatin in vitro and in cells. Furthermore, we
have provided evidence of a role for FACT in RNA Pol III
transcription through chromatin in cells.
Discussion
Although FACT has been regarded as a general chromatin
structure modulator for transcription (Reinberg and Sims,
2006), its involvement in this process beyond Pol II-depen-
dent chromatin transcription elongation had remained largely
uncharacterized. A potential nucleolar function of FACTcould
be inferred from previous studies that demonstrated its
presence in the nucleoli of mammalian cells (Andersen
et al, 2002) and its association with the nucleolar organizer
of Drosophila polytene chromosomes (Saunders et al, 2003).
Although consistent with a role for FACT in rDNA transcrip-
tion, the presence of FACT in nucleoli might also reﬂect its
roles in rDNA replication (Tan et al, 2006), DNA damage
detection and response (Bruhn et al, 1992; Keller et al, 2001;
Yarnell et al, 2001) and/or DNA repair (Heo et al, 2008). A
recent report indicated that FACT and nucleolin, which pos-
sesses a similar histone chaperone activity (Angelov et al,
2006), are each sufﬁcient to drive efﬁcient Pol I transcription
of an in vitro assembled chromatin template (Rickards et al,
2007). Yet evidence linking FACT to Pol I-dependent tran-
scription in cells was missing. Here, we have provided
evidence for the physical and functional interaction of FACT
with Pol I complexes, as well as a physiological role for FACT
in rRNA gene expression regulation in cells. Our data also
suggest a role for FACT in transcription through chromatin of
Pol III-transcribed genes. Therefore, this study extends the
known biological roles for this histone chaperone and chro-
matin remodelling complex to chromatin transcription by all
three nuclear RNA Pols. Moreover, our ﬁndings imply that
local chromatin dynamics have a critical impact on the
expression of Pol I- and III-transcribed genes.
In recent years, it has become increasingly clear that in
many genes Pol II is stalled at promoter proximal regions,
poised for transcriptional activation, and that the expression
of genes is therefore regulated post-initiation at the steps of
promoter escape and elongation of transcription (Saunders
et al, 2006; Muse et al, 2007; Zeitlinger et al, 2007). In the
expression of the mammalian rRNA genes, post-initiation
events are also important, as activator UBF has been shown
to facilitate promoter escape by Pol I (Panov et al, 2006a), and
binding of UBF throughout the rDNA repeat chromatin
modulates elongation of Pol I transcription (Stefanovsky
et al, 2006). The rate of rRNA synthesis and the linked
processing events (Schneider et al, 2007) depend upon the
efﬁciency by which Pol I negotiates rDNA chromatin, and our
identiﬁcation of the histone chaperone FACT as a Pol I
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Figure 6 FACT is present at the chromatin of genes transcribed by
all three nuclear RNA polymerases. (A) Schematic representation of
the rDNA repeat region indicating the positions of the PCR primers
used in chromatin immunoprecipitation (ChIP) analysis. (B) ChIP
assays were performed on formaldehyde crosslinked chromatin
from HeLa cells using antibodies speciﬁc for FACT subunit SSRP1
(monoclonal 10D1) or control mouse antibodies (IgG). Primer sets
used in the quantitative real-time PCR for the Pol I-transcribed
rDNA repeat were as follows: the ribosomal DNA promoter (pro-
moter, 1), 50-ETS (2), 18S (3) or 28S (4) gene region, or the non-
transcribed intergenic spacer (IGS; 5) of the rDNA repeat (indicated
in (A)). PCR primers also included those that detect the g-actin gene
transcribed by Pol II and four Pol III-transcribed genes (5S rRNA, U6
snRNA, tRNA
Tyr and 7SL RNA). The bar graph shows the relative
levels of bound DNA in the SSRP1 immunoprecipitates, as deter-
mined by quantitative RT–PCR; results from three independent ChIP
experiments combined are expressed as a percentage of input
chromatin (and standard deviation), normalized to control IgG
samples.
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in ribosomal DNA transcription. Indeed, various chromatin
remodellers and modiﬁers with a function in Pol I-dependent
transcription have recently been identiﬁed (reviewed in Birch
and Zomerdijk, 2008), including NoRC, an ATP-dependent
nucleosome remodeller (SNF2; Strohner et al, 2001; Li et al,
2006), which can additionally recruit histone deacetylases
and DNA methyltransferases such as DNA methyltransferase
1 and 3 (Santoro et al, 2002; Zhou et al, 2002; Zhou and
Grummt, 2005; Espada et al, 2007); WICH, a chromatin
remodelling complex containing WSTF (Williams syndrome
transcription factor) and SNF2h (Percipalle et al, 2006);
AB
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Figure 7 RNAi-mediated downregulation of FACT expression in cells leads to a decrease in the synthesis of RNAs from Pol I- and
Pol III-transcribed genes. (A) Whole-cell extracts (20mg) of HeLa cells transfected with various amounts of SSRP1-speciﬁc siRNAs
(sc-37877; lanes 1–4) or with control siRNAs (control sc-36869, lane 5) were immunoblotted using antibodies speciﬁc for FACT subunit
SSRP1 (top panel) or Pol I subunit PAF53 (bottom panel). (B) HeLa cells were transfected with 20nM of SSRP1-speciﬁc siRNA (SSRP1, lanes 3
and 4) or control siRNA (control, lanes 1 and 2) as in (A), then total RNAwas extracted from the cells at 24h (lanes 1 and 3) and 48h (lanes 2
and 4) post-transfections. The levels of 47S pre-rRNAwere analysed in a northern blot probed with a
32P-labelled DNA probe complementary to
a region from þ81 to þ125 relative to the transcription start site (top panel). The levels of 28S and 18S rRNAwere assessed in a 0.8% agarose
denaturing gel, stained with ethidium bromide (bottom panel). The levels of 47S pre-rRNA (24h post-transfections) of two independent
experiments were quantiﬁed by phosphorimaging, normalized to 28S rRNA levels, calculated as a percentage relative to the maximum level
(set at 100%) in the control siRNA-treated cells. The data of duplicate samples are presented as the average and range. (C) HeLa cells grown on
coverslips were transfected with plasmids expressing control or SSRP1-speciﬁc siRNAs (si-SSRP1) and 54h post-transfection nascent RNA
synthesis was visualized through a 10min BrUTP labelling of cells. Cells were probed with antibodies for SSRP1 (green) and BrdU (red). Within
the same microscopy ﬁeld, a mixture of cells can be seen in the bottom of the siSSRP1 panels; some cells have reduced levels of SSRP1 and
BrUTP incorporation (white arrowheads), whereas others appear to have levels unaffected and hence serve as an internal reference. All images
were generated at pre-set levels of brightness/contrast and laser intensity, by laser scanning confocal microscopy, and single sections are
shown (scale bar is 10mm). (D) Total RNA was extracted 24h after HeLa cells were transfected with 20nM of speciﬁc (SSRP1, grey bars) or
control siRNA (control, black bars) as in (A). Samples were analysed by S1 nuclease protection with an oligonucleotide probe complementary
to þ1t oþ40 of the 47S pre-rRNA. A representative phosphorimage of the protected 40nt S1 probe is shown on the left. S1 signals from two
experiments were quantiﬁed with the aid of a phosphorimager, normalized to 28S rRNA levels (as derived from the ethidium bromide image of
the same samples analysed on denaturing agarose gels, see (B)), calculated as a percentage relative to the maximum level (set at 100%) in the
control siRNA-treated cells. The data of duplicate samples are presented as the average and range. (E) RNAi-mediated downregulation of FACT
expression in HeLa cells reduced pre-rRNA levels. RNAi-mediated downregulation of SSRP1 or hSpt16 expression was assessed by
immunoblotting with antibodies for SSRP1 or hSpt16 (lanes 1 and 3, respectively) and compared with controls (lanes 2 and 4). Actin was
used as a control for equal loading of the cell extracts. The levels of 47S pre-rRNA in SSRP1 (grey bar) and hSpt16 (white bar) RNAi-treated
cells were determined by qRT–PCR from three independent experiments. The results were normalized to 18S rRNA levels of the respective
samples, and the mean and standard deviation values have been plotted. (F) The levels of tRNA
Tyr and 7SL RNA from two independent
experiments were determined by qRT–PCR in cells treated with SSRP1-RNAi (grey bar) or control RNAi (black bar). The levels were normalized
to GAPDH mRNA levels and expressed as a percentage of those detected in control RNAi-treated cells. The data of duplicate samples are
presented as the average and range.
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SWI/SNF family of ATP-dependent chromatin remodelling
activities (Bradsher et al, 2002); Tip60, a histone acetyl
transferase complex (Halkidou et al, 2004) and histone
methyltransferase G9a (Yuan et al, 2007b). Furthermore,
chromatin transcription by mammalian Pol I appears to
require the histone chaperone activities provided by nucleo-
lin (Angelov et al, 2006; Rickards et al, 2007) and nucleo-
phosmin (B23; Okuwaki et al, 2001; Murano et al, 2008), as
well as the activity of FACT. The involvement of multiple
factors, with the potential for functional redundancy, both
ensures the robustness of the system and implies that chro-
matin remodelling is crucial for transcription elongation by
Pol I in cells.
New ﬁndings linking distinct histone tail modiﬁcation
patterns with active rDNA gene repeats further support the
notion that rRNA expression is under epigenetic control
(reviewed in Grummt and Pikaard, 2003; McStay, 2006;
Birch and Zomerdijk, 2008); the promoters of actively tran-
scribed mouse rRNA genes are hypomethylated (Santoro et al,
2002; Nemeth et al, 2008) and the associated histones are
highly acetylated, with the opposite true of inactive gene
promoters (Santoro et al, 2002). FACT activity has been
shown to be inﬂuenced by histone modiﬁcations, such as
trimethylation of H3K4, which marks active genes including
those of the active rRNA gene repeats (Preuss and Pikaard,
2007), and monoubiquitination of H2A and H2B (Pavri et al,
2006; Zhou et al, 2008). Furthermore, the chromatin remo-
deller CHD1, which binds H3K4me3 and cooperates with
FACT (Sims et al, 2007), has been found at active rDNA
repeats in yeast (Jones et al, 2007). It will be interesting to
determine whether such histone modiﬁcations and interacting
factors also inﬂuence rRNA gene expression through FACT. As
FACT can be post-translationally modiﬁed, for example, by
CK2 or PARP1 (Li et al, 2005; Heo et al, 2008), rRNA gene
expression might also be rapidly modulated by such activities.
There are data to suggest that Pol III-transcribed genes are
devoid of nucleosomes (Wittig and Wittig, 1982; Morse et al,
1992) and that Pol III has the intrinsic ability to transcribe a
short mono-nucleosomal template in vitro without the need
for additional activities (Studitsky et al, 1997). Nonetheless, a
substantial number of studies suggest that chromatin remo-
delling and/or histone modiﬁcation are required for initiation
and elongation of Pol III transcription through nucleosomal
arrays in vitro and in cells (Englander et al, 1993; Ura et al,
1997; Tse et al, 1998; Ng et al, 2002; Gelbart et al, 2005;
Cavellan et al, 2006; Shivaswamy and Bhargava, 2006; Yuan
et al, 2007a; Arimbasseri and Bhargava, 2008). Furthermore,
TFIIIC, required at type 1 and 2 promoters of Pol III-tran-
scribed genes, has intrinsic histone acetyltransferase activity
(Hsieh et al, 1999; Kundu et al, 1999). Our study now
implicates the histone chaperone FACT in the transcription
by Pol III of small RNA genes in chromatin, thus further
underscoring the importance of chromatin remodelling at
actively transcribed Pol III genes. Previous immunoﬂuores-
cence studies of FACT at Drosophila polytene chromosomes
did not reveal FACT at the Pol III-transcribed 5S rRNA gene
cluster (Saunders et al, 2003). Perhaps this discrepancy is due
in part to a low abundance of FACT at this cluster—in
mammalian cells, our ChIP analyses suggest a lower occu-
pancy of FACTat the Pol III-transcribed genes, compared with
the Pol I- and Pol II-transcribed genes.
In Pol II transcription, some RNA Pol complexes were
found associated with FACT, consistent with previous obser-
vations in Drosophila (Saunders et al, 2003), but the recruit-
ment of FACT to active genes might be dependent primarily
on its association with other chromatin remodellers, such as
CHD1, and with trimethylation of histone H3 at Lys4 (Sims
et al, 2005, 2007). The association of FACT with Pol III is
probably also substoichiometric. In Pol I transcription, the
unique stoichiometric association of FACT with Pol I com-
plexes suggests that coupling of this histone chaperone to the
Pol complexes may be required to achieve efﬁcient rDNA
transcription through chromatin, to meet the demand for
the vast amounts of rRNAs necessary to support ribosome
biogenesis during active cell growth and proliferation.
Although the exact nucleosomal nature of active mamma-
lian rDNA chromatin is currently unknown, our ﬁndings
imply that nucleosomal barriers are encountered by Pol I at
active genes and/or at de novo activated rRNA genes during
pioneering rounds of transcription. We propose that nucleo-
somal barriers can be overcome by Pol I-associated FACT
activity, perhaps in conjunction with other FACT-like histone
chaperones and chromatin remodellers, to allow for produc-
tive elongation of transcription and rRNA synthesis. Our data
also strongly suggest that Pol III requires auxiliary factors
with histone chaperone activity to facilitate transcription and
passage of Pol III through nucleosomes in cells. Therefore,
histone chaperone FACT could be universally involved in
chromatin dynamics and transcription by all three nuclear
RNA Pols in mammalian cells.
Materials and methods
Reconstitution of mono- and poly-nucleosomal DNA
templates and the H2A–H2B dimer displacement assay
Preparation of mono- and poly-nucleosomal DNA templates is
detailed in the Supplementary data. The 147bp mouse mammary
tumour virus NPS A plus an extra 31bp 50 of the positioning
sequence (Flaus and Richmond, 1998) was used for the mono-
nucleosomal template and a series of twelve 5S rDNA NPSs was
used to create the poly-nucleosomal template. Escherichia coli-
expressed Xenopus laevis recombinant histones (Luger et al, 1997)
were used to refold the octamer and these were reconstituted with
the template DNA by salt dialysis. The mono-nucleosomal
reconstituted templates were incubated with 5U of AvaII (New
England Biolabs) for 15min at 371C to digest the relatively small
fraction of non-reconstituted DNA prior to and during the end-to-
end transcription reaction.
Crosslinking of histones in the octamer of a mono-nucleosomal
template with BS
3 and the H2A–H2B dimer displacement assay are
detailed in the Supplementary data.
Transcription assays
Transcription reactions with nucleosomal templates and nonspeciﬁc
transcription reactions were performed essentially as described
(Miller et al, 2001; Panov et al, 2006a) and are detailed in the
Supplementary data. The radiolabelled RNA was analysed by
denaturing gel electrophoresis (7.5M urea and 8% polyacrylamide)
with RNA markers (T3 and T7 RNA Pol body-labelled run-off
transcripts). End-to-end transcript levels were quantiﬁed with the
aid of a Fuji phosphorimager (and Aida software).
In the FACT antibody inhibition experiments, Pol Ia was
preincubated with SSRP1-speciﬁc antibodies (Santa Cruz Biotech-
nology; sc-25382) or control rabbit IgG for 10min at 301C prior to
the initiation of transcription on mono- or non-nucleosomal
templates.
Pol Ia puriﬁcation and mass spectrometry
Pol Ia was puriﬁed from HeLa nuclear extracts through a series of
chromatographic steps, including Superose 6, DEAE Sepharose, SP
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gradient elution from a Mono-S column (GE Healthcare) as
described previously (Miller et al, 2001). Proteins in the Pol Ia
peak fraction from the Mono-S column were size-fractionated in a
4–12% NuPAGE Bis–Tris gel (MES buffer; Invitrogen), and
individual gel slices were digested with trypsin and LysC. Tandem
mass spectrometry (LC MS/MS) was used in peptide analysis and
protein identiﬁcation as described (Andersen et al, 2002).
Immunoblotting, immunoprecipitation and
immunoﬂuorescence microscopy
Antibodies speciﬁc for SSRP1 (Santa Cruz Biotechnology; sc-
25382), Spt16 (sc-28734), PAF53 (Pol I subunit; BD Transduction
Laboratories; P95220), hRPA19 (Pol I and III subunits; Miller et al,
2001) or hRRN3 (afﬁnity puriﬁed sheep polyclonal antibody; Miller
et al, 2001) were used for immunoblotting and immunoprecipita-
tion, and primary antibodies for SSRP1 (monoclonal antibody 10D1;
Tan and Lee, 2004) and CAST/PAF49 (Bethyl Laboratories; A301-
294A) were used in immunoﬂuorescence microscopy as detailed in
the Supplementary data.
The SSRP1 (10D1) monoclonal antibody was used for immuno-
precipitation of FACT from HeLa cell nuclear extract, as detailed in
the Supplementary data, and the blots were probed with antibodies
for CAST (Pol I subunit; Bethyl Laboratories; A301-294A), RNA Pol
II (mouse monoclonal antibody for the C-terminal domain of the
largest subunit of Pol II; CTD4H8, Santa Cruz Biotechnology; sc-
47701) and RPC5 (Pol III subunit 5 or POLR3E; Abgent; AP1956c).
RNA interference and analysis of rRNA synthesis
RNA interference strategies are described in the Supplementary
data. The 47S pre-rRNA levels were determined by northern
blotting (probed with a
32P end-labelled oligonucleotide comple-
mentary to the 50-end of the pre-rRNA; 81–125 relative to the
transcription start site at þ1; human rDNA sequence U13369) and
S1 nuclease protection as described (James and Zomerdijk, 2004).
Levels of the precursors for tRNA
Tyr and 7SL RNA were determined
by quantitative RT–PCR (with primers identical to those used in the
ChIP assay, see below) and normalized to GAPDH mRNA levels as
described in the Supplementary data. BrUTP incorporation and
microscopy are detailed in the Supplementary data.
ChIP
ChIP assays were performed essentially as described (Tan et al,
2006). Brieﬂy, exponentially growing HeLa cells were crosslinked
with 1% formaldehyde for 10min at 371C. The nuclei were isolated
and sonicated to yield chromatin fragments of B500–600bp in
length. The sheared chromatin was immunoprecipitated overnight
with protein G-agarose previously bound with the SSRP1 mono-
clonal antibody (10D1) or control IgG antibody. After extensive
washes, the immunoprecipitates were subjected to deproteination
and crosslinking reversal. The following primer sets in the human
rDNA repeat were used for the quantitative real-time PCR analyses
(numbering according to the human rDNA repeat sequence U13369;
1 is the transcription start site): rDNA promoter (42787–42811 and
9–33), 50-ETS (1477–1496 and 1555–1572), 18S rRNA gene (3990–
4010 and 4072–4092), 28S rRNA gene (9546–9565 and 9869–9889)
and the IGS (35176–35200 and 35231–35346). For the Pol II-
transcribed g-actin gene (990–1009 and 1102–1123) we used: 50-
GCTGTTCCAGGCTCTGTTCC-30 (sense), 50-ATGCTCACACGCCA-
CAACATGC-30 (antisense). The primers for the Pol III-transcribed
genes were as follows: 5S rRNA gene (6–24 and 84–103), 50-CGG
CCATACCACCCTGAAC-30 (sense), 50-GCGGTCTCCCATCCAAGTAC-
30 (antisense); U6 snRNA gene (7–31 and 69–89), 50-GCTTCGGCAG-
CACATATACTAAAAT-30 (sense), 50-ACGAATTTGCGTGTCATCCTT-30
(antisense); tRNA
Tyr gene (1–30 and 55–84, relative to the precursor
transcript; intron: 38–58), 50-CCTTCGATAGCTCAGCTGGTAGAGCG-
GAGG-30 (sense), 50-CGGAATTGAACCAGCGACCTAAGGATGTCC-30
(antisense); 7SL RNA gene (107–137 and 226–255), 50-GTGTCCGCA
CTAAGTTCGGCATCAATATGG-30 (sense), 50-TATTCACAGGCGC-
GATCCCACTACTGATC-30 (antisense). The primer sequences for
the Tyr-tRNA and 7SL RNA genes were designed based on a
previous report (Winter et al, 2000). PCR conditions: 25–27
cycles, with each cycle for 45s at 941C, for 45s at 50–521C and
40s at 721C. DNA samples from ChIP preparations were quantiﬁed
by real-time PCR with an ABI Prism 7000 instrument using
SYBR Green PCR Master Mix (both Applied Biosystems). Triplicate
PCRs for each sample were carried out. Control ChIP assays
with nonspeciﬁc antisera (IgG) were performed in each experiment.
The relative proportions of immunoprecipitated DNA fragments
were determined based on the threshold cycle (Ct) for each
PCR product (Livak and Schmittgen, 2001). Data were quantita-
tively analysed according to the formula 2 D½CtðIPÞ CtðinputÞ   
2 D½CtðcontrolIgGÞ CtðinputÞ  , which normalized the relative level of
DNA (in relation to the input) speciﬁcally immunoprecipitated by
the SSRP1 antibody to that immunoprecipitated by the control IgG.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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